Sonova Holding (OTCMKTS:SONVY – Get Free Report) has been assigned a consensus rating of “Hold” from the seven ratings firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, two have assigned a buy recommendation and one has issued a strong buy recommendation on the company.
SONVY has been the subject of a number of recent analyst reports. Citigroup reiterated a “sell” rating on shares of Sonova in a research report on Friday, July 24th. Morgan Stanley upgraded shares of Sonova from an “underweight” rating to an “equal weight” rating in a research report on Tuesday, June 23rd. Finally, UBS Group upgraded Sonova from a “hold” rating to a “buy” rating in a research note on Wednesday, July 22nd.
Check Out Our Latest Analysis on SONVY
Sonova Stock Up 1.4%
About Sonova
Sonova Holding AG is a Switzerland-based company focused on hearing care and hearing solutions. Through its businesses, the company develops, manufactures and distributes hearing aids, cochlear implants and other hearing-related technologies designed to help people with hearing loss communicate and participate more fully in daily life.
Sonova’s portfolio includes hearing instruments and accessories, wireless communication products, implantable hearing systems and audiological services.
Further Reading
- Five stocks we like better than Sonova
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.
